Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
about
Interventions for drooling in children with cerebral palsyInterventions for drooling in children with cerebral palsyInterventions for drooling in children with cerebral palsyRandomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.Drooling.Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.Sialorrhea - therapeutic drug options.A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.Effect of recurrent onabotulinum toxin A injection into the salivary glands: An ultrasound measurement.Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditionsClozapine-induced sialorrhea: pathophysiology and management strategies.Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group.Sialorrhea in Parkinson's disease: a review.Clozapine-induced hypersalivation: a review of treatment strategies.Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study.Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement.Current treatment strategies for clozapine-induced sialorrhea.Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children.Dysphagia and aspiration in children.Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.Botulinum toxin for the treatment of sialorrhea: a meta-analysis.The role of radiation therapy in the management of sialorrhea: A systematic review.[Amyotrophic lateral sclerosis: management of bulbar symptoms].Ipratropium bromide for treatment of bethanechol-induced sialorrhea.EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives.Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.Prioritising drugs for single patient (n-of-1) trials in palliative careValidation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: A study in a large French cohortTHEME 11 IMPROVING DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION
P2860
Q24202858-BFF5E436-231B-4E60-A27E-36BBDF9D002FQ24203689-E971174D-C1D5-4DCC-BF0B-BF6D37C12A56Q24234533-8AEB325C-1DFC-4D58-A41A-7474A4890C27Q30428628-7834C041-69E2-4A39-A2C8-00323FEF9F66Q33411521-966C7958-14A3-40C3-878D-816D4562CED1Q34036853-58E7B44B-3BEB-4C6E-8159-87B928A50351Q34156159-95C3B564-E1F4-44AB-95EC-D80BCF087902Q35538621-919F9E6D-2D2A-43AF-9D31-23897D33BC0AQ35704327-BDF74307-3977-4F69-8E89-ECAB4173F45BQ35717065-3070B8FC-765A-444E-9663-C7493D4C9E5AQ36412431-2ABFEF45-2D67-479E-9C12-3DE4B4C4A503Q36892306-4B643712-9518-4214-A40E-F45FCDE17AA9Q36894731-D98F1041-3F03-429C-A38D-9E869AF3661FQ36908979-EA644C5B-201B-48A5-8804-0E5552F9B1BAQ37426278-463DD266-EA3F-42B5-9090-86E14A55CFB4Q37516494-683E813E-9BEE-477B-9B25-D0F000370E24Q37608227-B032AF3B-35E2-46D0-B5AC-A05925FC0EE2Q37663865-EF2CA211-5D04-432E-B315-4824FCED1F28Q37772981-FC01B7A7-A0B3-4DBB-B182-0FC29A59BBDBQ37871724-604B6238-7C10-4D21-95EF-507DCEFBD7A4Q37946363-3949CD45-D1E2-4111-BC79-588E3B695EF2Q37947190-BDAF2039-1071-4107-AC25-A8EC8C9493C6Q38014475-CC3B3C40-4D5C-41FE-AE55-6233579C0D8EQ38056701-33285D5E-F356-4989-8E55-28DC9DF98E0EQ38543693-EA1E2212-3A52-4C37-89A7-25DD9BCE64BBQ43094424-597674F1-65E6-4322-904D-13593496D2E3Q44551456-1F95BFC9-6216-44E4-8A1B-37B9A2D57D59Q46832663-4E23C6A2-E1BE-49C8-B88A-6AF4F09A0E33Q49387065-178FE3D6-9CDB-4A18-B31F-9883137581E6Q53485992-2C9BD992-16F6-4634-AE40-2AFAB43DB049Q57360777-02F642F4-264E-4E5C-BF31-22A9E0780527Q58280431-4ABB604C-7984-47DF-BA5F-6068F2B28C69Q58286428-70E6711C-51A8-429E-8D9D-9E130E9A83FD
P2860
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
@ast
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
@en
type
label
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
@ast
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
@en
prefLabel
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
@ast
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
@en
P2093
P1433
P1476
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
@en
P2093
P304
P356
10.1001/ARCHPEDI.154.12.1214
P407
P577
2000-12-01T00:00:00Z